PIK3CD and metastatic neoplasm: We employed the PI3K signature score developed by Gustafson29, as a measure of PI3K pathway activation, on the set of paired primary and metastatic tumors, and found a tendency of increased PI3K activation in metastases (borderline significance of p = 0.055; Fig. 4c).